triazolam
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
12 FDA-registered drug labelers
A-S Medication Solutions
Aphena Pharma Solutions - Tennessee, LLC
Bryant Ranch Prepack
Cambrex Profarmaco Milano Srl
Ingenus Pharmaceuticals, LLC
Mylan Pharmaceuticals Inc.
PD-Rx Pharmaceuticals, Inc.
Pfizer Ireland Pharmaceuticals Unlimited Company
Pharmacia & Upjohn Company LLC
Pharmacia and Upjohn Company LLC
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Triazolam
- •Halcion
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Triazolam Tablet
09/29/2025Chemical Identity
CAS28911-01-5
PubChem CID5556
DTXSIDDTXSID6046763
FormulaC17H12Cl2N4
Mol. Weight343.2 g/mol
SMILESCC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
Data Sources
55562026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/triazolam/cids/JSON
Archive: data/sources/pubchem_name/triazolam.json
CAS 28911-01-52026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 28911-01-52026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json